Krystal Biotech, Inc. beat EPS estimates 100% of the time across 2 reported quarters (2 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $1.70 | $1.79 | +5.3% | Beat |
| Q12026 FY2026 | $1.45 | $1.83 | +26.2% | Beat |
| Q42025 FY2025 | $1.62 | — | — | Miss |
Back to KRYS overview · KRYS holders · KRYS KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.